$GTCH The device includes sensors for oxygen (SPO2), heart rate and IR (Infra-Red) type for temperature. A coprocessor chip provides an advanced adjusting algorithm to support broader user’s measuring habits, while compensating for different inputs. The device is accompanied by a smartphone app and synchronized web application to keep a history and provide analytics. This larger scale testing phase data is targeted to also to be used for the FDA certification process, certification which there is no guaranty the Company will be able to obtain.
https://www.marketwatch.com/press-release/gbt...ws_seemore
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!